Sherman Darren
See Remarks
Sherman Darren has filed 11 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Sherman Darren is listed as See Remarks at Orchestra BioMed Holdings, Inc. Inside the rolling window, Sherman Darren reported 1 open-market purchase totaling $11K in OBIO and 4 open-market sales totaling $258K in OBIO. The largest disclosed transaction in the window is a sale of 15,000 OBIO shares on Sep 1, 2026, worth $74K.
Companies traded
Other insiders at OBIO
Insider Buying
$11K
reported purchases (SEC code P)
Insider Selling
$258K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sherman Darren made?
Sherman Darren has filed 11 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Sherman Darren trade?
Sherman Darren has filed SEC Form 4 disclosures for 1 company, including OBIO.
When was Sherman Darren's most recent SEC Form 4 filing?
Sherman Darren's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Sherman Darren's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sherman Darren is listed as See Remarks.
What is Sherman Darren's total buy and sell value in the current window?
Inside the rolling retention window, Sherman Darren bought $11K and sold $258K based on SEC Form 4 filings.
What was Sherman Darren's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 OBIO shares on 2026-09-01, worth $74K, per SEC Form 4 filings.